Nurse Practitioner, Acute Care · Allentown, PA
NPI
1942768619
Since 2019
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1250 S Cedar Crest Blvd
Allentown, PA, 18103
Phone (610) 402-3311
Groups this clinician bills Medicare through
Medicare paid, 2024
$129K
2,977 services
Medicare patients, 2024
783
Average age 77
Drug cost, 2024
$912K
2,172 prescriptions
Company payments, 2025
$687
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Allyson Buckshaw was code 99214 (office e&m - established), 1,365 times for 727 patients. In total Allyson Buckshaw billed 2,977 services in 12 codes, and Medicare paid $129K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,365 | 727 | $77.45 | $106K |
| 93000 Electrocardiogram | Office | 813 | 556 | $8.70 | $7,076 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 643 | 427 | $10.89 | $7,002 |
| 99215 Office E&M - Established | Office | 57 | 57 | $104.51 | $5,957 |
| 99211 Office E&M - Established | Office | 50 | 21 | $14.65 | $732 |
| G0250 Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 15 | 12 | $4.96 | $74.44 |
| 99204 Office E&M - New | Office | 12 | 12 | $100.79 | $1,210 |
| 99213 Office E&M - Established | Office | 11 | 11 | $58.36 | $642 |
By year: 2022 $41K for 1,265 services; 2023 $88K for 1,571 services; 2024 $129K for 2,977 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 24 | 22 | $4.20 | $101 |
Medicare prescription drug claims, 2024
In 2024, the drug Allyson Buckshaw prescribed most often to Medicare patients was Eliquis (Apixaban), with 279 prescriptions and refills. In total Allyson Buckshaw wrote 2,172 Medicare prescriptions that cost $912K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 279 | 503 | 85 | $281K |
| Metoprolol Succinate Generic | 275 | 718 | 111 | $4,089 |
| Valsartan Generic | 206 | 428 | 64 | $7,204 |
| Sotalol Sotalol Hcl | 138 | 291 | 45 | $3,265 |
| Amiodarone Hcl Generic | 102 | 291 | 42 | $1,919 |
| Furosemide Generic | 80 | 184 | 39 | $341 |
| Dofetilide Generic | 69 | 177 | 22 | $19K |
| Xarelto Rivaroxaban | 66 | 126 | 22 | $68K |
| Entresto Sacubitril/Valsartan | 59 | 109 | 23 | $70K |
| Sotalol Af Sotalol Hcl | 57 | 141 | 24 | $2,516 |
| Losartan Potassium Generic | 55 | 125 | 19 | $513 |
| Multaq Dronedarone Hcl | 51 | 80 | 18 | $62K |
| Amlodipine Besylate Generic | 50 | 118 | 22 | $436 |
| Hydrochlorothiazide Generic | 46 | 124 | 20 | $192 |
| Metoprolol Tartrate Generic | 44 | 112 | 19 | $322 |
Brand drugs: 535 claims; generic drugs: 1,637 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Allyson Buckshaw $687 ($687 in general payments such as food, travel and fees) from 13 companies. The largest payer was ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) with $203.
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $203 |
| Shockwave Medical, Inc JNJ | 1 | $124 |
| Abbott Laboratories ABT | 1 | $118 |
| Pfizer Inc. PFE | 2 | $46.91 |
| Kestra Medical Technology Services, Inc. | 2 | $32.83 |
| Boston Scientific Corporation BSX | 1 | $31.73 |
| Merck Sharp & Dohme LLC MRK | 1 | $24.81 |
| Scpharmaceuticals Inc. SCPH | 1 | $21.13 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $18.61 |
| Esperion Therapeutics, Inc. ESPR | 1 | $18.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.